About Cytek Biosciences, Inc. 
Cytek Biosciences, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 46 Schemes (31.3%)
Foreign Institutions
Held by 72 Foreign Institutions (7.97%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
44 Million
(Quarterly Results - Mar 2026)
Net Profit:
-19 Million
Pharmaceuticals & Biotechnology
USD 555 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.71
-19.47%
1.62






